Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...

More research is needed to confirm gray matter, the darker tissue found in the brain and spinal cord, “as a potential disease ...

From February 12, all newborn babies will be offered screening for spinal muscular atrophy (SMA), a rare progressive neuromuscular disease. SMA will be one of more than 20 other rare disorders ...

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

The first-in-human trial saw all three patients able to increase their walking distance within six minutes to 20 meters.

From February 12, all newborn babies will be offered screening for spinal muscular atrophy (SMA), a rare progressive neuromuscular disease. SMA will be one of more than 20 other rare disorders ...

Health activists demand government action to reduce the cost of SMA medicines, citing constitutional obligations and ...

Request To Download Free Sample of This Strategic Report @ Introduction Spinal Muscular Atrophy (SMA) is a rare genetic disorder characterized by the progressive loss of motor neurons, leading to ...

Application is supported by results from the DEVOTE study, which suggested that two doses of Spinraza (nusinerse) 50 mg taken ...